The Canadian Institutes for Health Research (CIHR) today announced $800,000 in funding to expand Simon Fraser University’s iReceptor initiative. It is expected that this funding will be part of a Canada/EU flagship project totaling more than $12M Canadian over four years. iReceptor is a newly developed platform for managing massive repositories of worldwide distributed data that researchers can securely access in their…
Read More
The Rennie and Cherkasov labs have a long history of developing therapeutics to target the function of transcription factors that drive advanced and metastatic forms of endocrine cancers. Currently, our main focus is to use Computer-Aided Drug Design (CADD) to create small-molecule inhibitors of the androgen receptor (AR), a hormone inducible transcription factor that is responsible for the disease progression of prostate cancer (PCa)...
Read More

2018 Faculty of Medicine Award Recipients

Each year, the Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. Amongst other award winners, Dr. John Cairns in the UBC Department of Medicine has been awarded the UBC Award for Excellence in Mentoring Early Career Faculty. This award recognizes faculty members who have formally been identified as mentors and…
Read More

Concussions Loosen Insulation around Brain Cells

Detailed scans of concussed University of British Columbia hockey players found that the protective fatty tissue surrounding brain cell fibers was loosened two weeks after the injury—even though the athletes felt fine and were deemed ready to return to the ice. A loosening of that insulation, called myelin, slows the transmission of electrical signals between brain cells, or neurons. Researchers have…
Read More

CDRD Academy Announces Inaugural Cohort in Unique New National Executive Institute

CDRD – The Centre for Drug Research and Development, Canada’s national life sciences venture, is pleased to announce the first cohort of the CDRD Academy’s Executive Institute. Earlier this year, CDRD and Pfizer Canada announced the launch of the Executive Institute under the umbrella of The CDRD Academy. The Institute is a 10-month, focused executive development program open to a…
Read More
Vancouver urologists are shining new light — literally — on cancerous bladder lesions, with a new tool that makes malignant cells appear pink when fluorescent blue light is shone on them. The conventional tool used to see malignant cells in the bladder is a white light camera-tipped instrument called a cystoscope that’s passed through the urethra to the bladder. But…
Read More
Biochemist and molecular biologist Matthew Dahabieh (BSc 06’, MSc 08’, PhD 13’) originally planned to head to medical school, but along the way got sidetracked by a tiny but mighty microorganism. Now Dahabieh is on the lookout for problems he can solve with yeast. When did you get interested in research and development? Looking for opportunities in scientific research, I…
Read More
Cell autonomous immunity is the ability of individual cells to initiate a first line of host defense against invading microbes, such as viruses. Autophagy receptors, a diverse family of multivalent proteins, play a key role in this host response by detecting, sequestering, and eliminating virus in a process termed virophagy. To counteract this, positive-stranded RNA viruses, such as enteroviruses, have…
Read More

TRIUMF is Trying to Create the Rarest Drug on Earth

Using a particle accelerator, a team of scientists at TRIUMF is attempting to make a rare radioactive element, actinium, that could revolutionize cancer treatment. The video is created by Telus Storyhive, which supports compelling, original stories told by filmmakers from BC and Alberta by providing production funding, training and exposure to new audiences…
Read More